Published in Br J Pharmacol on December 01, 1970
Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Br J Pharmacol (1972) 4.45
Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics. Br J Pharmacol (1975) 3.76
Stimulation of Ca2+-dependent neurotransmitter release and presynaptic nerve terminal protein phosphorylation by calmodulin and a calmodulin-like protein isolated from synaptic vesicles. Proc Natl Acad Sci U S A (1979) 1.97
Inhibition of noradrenaline release by lysergic acid diethylamide. Br J Pharmacol (1973) 1.56
Variation in noradrenaline output with changes in stimulus frequency and train length: role of different noradrenaline pools. Br J Pharmacol (1974) 1.19
Effect of drugs on the synthesis of noradrenaline in guinea-pig vas deferens. Br J Pharmacol (1972) 0.89
An investigation of spontaneous potentials recorded from the smooth-muscle cells of the guinea-pig seminal vesicle. J Physiol (1972) 0.89
Formation of dopamine and noradrenaline in rat vas deferens: comparison with guinea-pig vas deferens. Br J Pharmacol (1975) 0.86
Tyrosine hydroxylase: activation by nerve stimulation. Proc Natl Acad Sci U S A (1974) 0.84
Release of monoamines from the striatum and hypothalamus: effect of -hydroxybutyrate. Br J Pharmacol (1972) 0.81
Noradrenaline synthesis after sympathetic nerve activation in rat atria and its dependence on calcium but not CAM kinase II and protein kinases A or C. Br J Pharmacol (1996) 0.75
Acceleration of catecholamine biosynthesis in sympathetically innervated tissues by angiotensin-II-amide.. Br J Pharmacol (1972) 0.75
TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS. J Biol Chem (1964) 5.40
PREGANGLIONIC AND POSTGANGLIONIC STIMULATION OF THE GUINEA-PIG ISOLATED VAS DEFERENS PREPARATION. Br J Pharmacol Chemother (1963) 4.66
An unusual type of sympathetic ganglionic stimulant. J Pharmacol Exp Ther (1961) 4.05
THE EFFECTS OF GANGLION-BLOCKING AND POSTGANGLIONIC SYMPATHOLYTIC DRUGS ON PREPARATIONS OF THE GUINEA-PIG VAS DEFERENS. Br J Pharmacol Chemother (1963) 3.62
Effects of tetrodotoxin on innervated smooth muscle preparations. Br J Pharmacol Chemother (1967) 3.59
Properties of the inhibitory potential of smooth muscle as observed in the response to field stimulation of the guinea-pig taenia coli. J Physiol (1967) 3.17
Inhibition by ganglionic blocking agents of the motor response of the isolated guinea-pig vas deferens to hypogastric nerve stimulation. Acta Physiol Scand (1962) 2.70
Increase in tyrosine hydroxylase activity after reserpine administration. J Pharmacol Exp Ther (1969) 2.32
Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation. J Pharmacol Exp Ther (1968) 1.99
Sympathetic denervation of the smooth muscle of the vas deferens. J Physiol (1970) 1.94
MICROMETHODS FOR MEASURING PHENYLALANINE AND TYROSINE IN SERUM. Clin Chem (1964) 1.90
The innervation of the vas deferens of the guinea-pig. J Physiol (1967) 1.84
The action of extracellular cations on the release of the sympathetic transmitter from peripheral nerves. J Physiol (1967) 1.73
The noradrenaline content of the vas deferens of the guinea-pig. Proc R Soc Lond B Biol Sci (1970) 1.58
Increased synthesis of norepinephrine and epinephrine in the intact rat during exercise and exposure to cold. J Pharmacol Exp Ther (1966) 1.58
The effects of inorganic ions on the storage and uptake of H3-norepinephrine by rat heart slices. J Pharmacol Exp Ther (1969) 1.55
The regulation of norepinephrine synthesis in sympathetic nerves: effect of nerve stimulation, cocaine, and catecholamine-releasing agents. Proc Natl Acad Sci U S A (1966) 1.43
Regulation of norepinephrine biosynthesis. Annu Rev Pharmacol (1970) 1.29
The estimation of catechol amines in urine. Acta Physiol Scand (1959) 1.28
Acceleration of noradrenaline biosynthesis by nerve stimulation. Life Sci (1966) 1.23
The effect of nerve stimulation on the synthesis and metabolism of norepinephrine in the isolated guinea-pig hypogastric nerve-vas deferens preparation. J Pharmacol Exp Ther (1968) 1.20
A kinetic study of bovine adrenal tyrosine hydroxylase. J Biol Chem (1966) 1.17
The action of reserpine on noradrenaline biosynthesis in sympathetic nerve tissue. Biochem Pharmacol (1968) 1.16
Acceleration of norepinephrine synthesis in the rat submaxillary gland in vivo during sympathetic nerve stimulation. Life Sci (1967) 1.15
Acceleration of noradrenaline turnover in the mouse heart by cold exposure. Life Sci (1965) 1.14
Localization of different steps in noradrenaline synthesis to different fractions of a bovine splenic nerve homogenate. Biochem Pharmacol (1967) 1.09
Increased synthesis of norepinephrine in the rat heart on electrical stimulation of the stellate ganglia. Mol Pharmacol (1966) 1.07
The uptake of tyrosine by rat brain in vitro. J Biol Chem (1961) 1.07
Increased synthesis and release of noradrenaline and dopamine during nerve stimulation. Life Sci (1967) 1.05
Increased synthesis of catecholamines in the intact rat following administration of alpha-adrenergic blocking agents. Mol Pharmacol (1968) 1.00
Factors influencing the rate of norepinephrine biosynthesis in nerve tissue. J Pharmacol Exp Ther (1967) 1.00
Inhibitors of endogenous catecholamine biosynthesis. Pharmacol Rev (1966) 0.99
Beef adrenal medulla dihydropteridine reductase. Biochim Biophys Acta (1969) 0.86
Drug-induced inhibition of noradrenaline synthesis in vitro in bovine splenic nerve tissue. Br J Pharmacol Chemother (1966) 0.84
Acceleration of the rate limiting step in norepinephrine biosynthesis by potassium. Experientia (1970) 0.81
Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA (2000) 10.40
Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature (1975) 10.33
Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A (2006) 10.24
Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. N Engl J Med (1999) 9.26
Endogenous opioid peptides: multiple agonists and receptors. Nature (1977) 8.21
Clinical and epidemiologic features of primary HIV infection. Ann Intern Med (1996) 6.04
Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med (1997) 5.72
Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA (1992) 5.07
Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol (1989) 4.96
Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep (1998) 4.85
The gene for familial polyposis coli maps to the long arm of chromosome 5. Science (1987) 4.48
Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Br J Pharmacol (1972) 4.45
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. Br J Pharmacol (1972) 4.11
The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology (1999) 3.78
Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics. Br J Pharmacol (1975) 3.76
The use of an optical brightener in the study of plant structure. Stain Technol (1975) 3.70
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol (2000) 3.27
Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res (1975) 3.26
Head and neck schwannomas--a 10 year review. J Laryngol Otol (2000) 3.25
Chronic conditions and risk of in-hospital death. Health Serv Res (1994) 3.00
Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol (1991) 2.89
Using conjoint analysis to assess women's preferences for miscarriage management. Health Econ (1997) 2.87
The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues. Br J Pharmacol (1977) 2.59
Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem J (1978) 2.41
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39
Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome. Nat Genet (1994) 2.35
Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther (2015) 2.34
Use of expiratory CT pulmonary angiography to reduce inspiration and breath-hold associated artefact: contrast dynamics and implications for scan protocol. Clin Radiol (2011) 2.30
Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements. Br Med J (1979) 2.30
Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase. Biochem J (1980) 2.24
Errors in using tobacco withdrawal scale. Tob Control (1998) 2.23
Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol (1971) 2.17
Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol (1999) 2.09
Osteopontin--a molecule for all seasons. QJM (2002) 2.09
Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann N Y Acad Sci (1992) 2.06
Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther (1973) 2.05
A randomised controlled trial of the effect of the provision of free school milk on the growth of children. J Epidemiol Community Health (1980) 2.04
Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science (1997) 2.01
Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol (1989) 2.01
The phototropin family of photoreceptors. Plant Cell (2001) 2.01
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol (2001) 1.98
A review of the epidemiological evidence for the 'antioxidant hypothesis'. Public Health Nutr (2004) 1.97
A prokaryotic phytochrome. Nature (1997) 1.91
Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol (2001) 1.90
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A (1999) 1.89
beta 3: an additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kinetics. Proc Natl Acad Sci U S A (2000) 1.89
Purification and properties of enkephalin - the possible endogenous ligand for the morphine receptor. Life Sci (1975) 1.88
An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care (2005) 1.87
Influence of dose and fiber type on respiratory malignancy risk in asbestos cement manufacturing. Am Rev Respir Dis (1979) 1.85
Value of routine chest radiography of psychiatric patients. Br Med J (1980) 1.84
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest (1994) 1.83
Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol (1997) 1.82
Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol (1998) 1.79
Incorporation of labelled amino acids into the enkephalins. FEBS Lett (1977) 1.73
Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int (2000) 1.72
Some thoughts on the significance of enkephalin, the endogenous ligand. Life Sci (1975) 1.71
Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc Natl Acad Sci U S A (2004) 1.69
On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. J Antibiot (Tokyo) (1978) 1.67
Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci U S A (1996) 1.66
The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X. Nature (2001) 1.63
Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol. Pediatr Pulmonol (2003) 1.61
Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat New Biol (1973) 1.61
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60
Characterization of recombinant phytochrome from the cyanobacterium Synechocystis. Proc Natl Acad Sci U S A (1997) 1.60
Intensive care-management at home: an alternative to institutional care? Age Ageing (2001) 1.58
Lead exposure in a firing range. Am J Public Health (1987) 1.58
In vitro pharmacology of the opioid peptides, enkephalins and endorphins. Eur J Pharmacol (1977) 1.56
Inhibition of noradrenaline release by lysergic acid diethylamide. Br J Pharmacol (1973) 1.56
Selective reduction of tryptophan hydroxylase activity in rat forebrain after midbrain raphe lesions. Brain Res (1971) 1.54
A systematic literature review of the effectiveness of non-pharmacological interventions to prevent wandering in dementia and evaluation of the ethical implications and acceptability of their use. Health Technol Assess (2006) 1.53
Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis (2001) 1.52
Lipid infusion in the management of poisoning: a report of 6 canine cases. Vet Rec (2013) 1.51
Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology. Stat Med (2001) 1.50
SnR30: a new, essential small nuclear RNA from Saccharomyces cerevisiae. Nucleic Acids Res (1988) 1.48
Adverse drug reactions in a paediatric intensive care unit. Acta Paediatr (1995) 1.47
Corneal astigmatism in preschool Native Americans. J Am Optom Assoc (1997) 1.46
The DSM-IV field trial for substance use disorders: major results. Drug Alcohol Depend (1995) 1.46
The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res (1990) 1.45
Choline: selective accumulation by central cholinergic neurons. J Neurochem (1973) 1.45
Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. Hum Mol Genet (1997) 1.45
Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease. Exp Neurol (1997) 1.43
The chemical stain removal properties of 'whitening' toothpaste products: studies in vitro. Br Dent J (2000) 1.43
The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med (2007) 1.43
Susceptibility to a parkinsonian toxin varies during primate development. Exp Neurol (2012) 1.41
The uptake and disposition of dl-norepinephrine in perfused rat lung. J Pharmacol Exp Ther (1969) 1.40
Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Kidney Int (2001) 1.40
Fetal neural graft survival. Lancet (1990) 1.40
Bridging the chasm: incorporating the medically compromised patient into psychiatric practice. J Psychosoc Nurs Ment Health Serv (1997) 1.39
Comment on Roth appliance. Am J Orthod Dentofacial Orthop (1993) 1.39
Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys. Exp Neurol (1999) 1.38
Midazolam infusion in a pediatric intensive care unit. Ann Pharmacother (1993) 1.38
Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci (1996) 1.38
Phytochrome Cph1 from the cyanobacterium Synechocystis PCC6803. Purification, assembly, and quaternary structure. Eur J Biochem (2001) 1.36
Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies. Eur J Clin Nutr (2004) 1.36
Evaluation of neuronal and extraneuronal uptake mechanisms during adrenergic nerve stimulation. Br J Pharmacol (1971) 1.34
The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nat Med (1998) 1.32